Aoife Brennan's Net Worth
$530 Thousand
Who is Aoife Brennan?
Aoife Brennan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include FIBROGEN INC, SYNLOGIC, INC., Ra Pharmaceuticals, Inc., Xilio Therapeutics, Inc., and Eliem Therapeutics, Inc..
SEC CIK
Aoife Brennan's CIK is 0001714563
Past Insider Trading and Trends
2023 was Aoife Brennan's most active year for acquiring shares with 12 total transactions. Aoife Brennan's most active month to acquire stocks was the month of May. 2023 was Aoife Brennan's most active year for disposing of shares, totalling 13 transactions. Aoife Brennan's most active month to dispose stocks was the month of October. 2024 saw Aoife Brennan paying a total of $0.00 for 945,000 shares, this is the most they've acquired in one year. In 2023 Aoife Brennan cashed out on 170,989 shares for a total of $92,331.22, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FIBROGEN INC (FGEN) Snapshot price: $0.3995
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
| +14.58% | 3.56K |
$17.19 | -$81,366.84 | 27.95K |
Jun 7 - Jun 9
| |||
Form 4
| +183.16% | 15.78K |
—
|
—
| 24.39K |
Jun 16
| |||
Form 4
| +120.08% | 4.7K |
—
|
—
| 8.61K |
May 26
| |||
Form 4
|
∞
| 3.91K |
—
|
—
| 3.91K |
Aug 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SYNLOGIC, INC. (SYBX) Snapshot price: $1.58
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 4
| -6.92% | -19.04K |
$0.58 | -$10,964.38 | 256.3K |
Apr 3
| |||
Form 4
| -3.13% | -8.89K |
$2.45 | -$21,753.83 | 275.34K |
Scheduled
|
Apr 4
| ||
Form 4
| +60.30% | 106.92K |
—
|
—
| 284.24K |
Feb 4
| |||
Form 4
| +67.17% | 71.25K |
—
|
—
| 177.32K |
Mar 10
| |||
Form 4
| +77.47% | 46.3K |
—
|
—
| 106.07K |
Mar 10
| |||
Form 4
| +15.45% | 8K |
—
|
—
| 59.77K |
Sep 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ra Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eliem Therapeutics, Inc. (ELYM) Snapshot price: $7.39
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||